Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14728-0 FLUoxetine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE FLUoxetine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14728-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 FLUoxetine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14729-8 Flurazepam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Flurazepam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14729-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Flurazepam SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Dalmane; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
1473-8 Follitropin^30M post 100 ug luteinizing releasing hormone IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --30 minutes post 100 ug luteinizing releasing hormone IV &nbsp; NAM DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1473-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FSH 30M p 100 ug LRH IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p 100 ug LRH IV; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14730-6 Flurazepam+N-desalkylflurazepam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14730-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Flurazepam+Desalkyl SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Dalmane; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Flurazepam+Desalkyl; Level; norfludiazepam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14731-4 Folate SCnc RBC Pt Qn &nbsp; &nbsp; ACTIVE Folate [Moles/volume] in Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14731-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Folate RBC-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Erythrocytes; Folat; Folic acid; Level; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; Vit M; Vitamin M 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14732-2 Folate SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Folate [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14732-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Folate SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Folat; Folic acid; Level; Pl; Plasma; Plsm; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit M; Vitamin M 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14733-0 Folate+Cyanocobalamin Imp Ser/Bld Pt Nom &nbsp; &nbsp; ACTIVE Folate+Cyanocobalamin [Interpretation] in Serum or Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14733-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Folate+Vit B12 SerBld-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood; c133; Chemistry; CN-Cbl; Folat; Folate+Vit B12; Folic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; SerBld; Serum; Serum or whole blood; SR; Vit B12; Vit M; Vitamin B12; Vitamin M; WB; Whole blood 2.26 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14734-8 Follitropin SRat Urine 24H Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14734-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 FSH 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; Follicle stimulating hormone; FSH; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14735-5 Gastrin^10M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14735-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 10M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 10M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14736-3 Gastrin^15M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14736-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 15M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 15M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14737-1 Gastrin^20M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14737-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 20M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 20M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14738-9 Gastrin^25M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14738-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 25M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 25M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14739-7 Gastrin^2M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14739-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 2M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
1474-6 Follitropin^30M post dose gonadotropin releasing hormone MCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1474-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FSH 30M p GnRH SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p GnRH; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14740-5 Gastrin^30M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14740-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 30M p 0.2 U/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14741-3 Gastrin^5M post 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14741-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 5M p 0.2 u/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 5M p 0.2 u/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14742-1 Gastrin^pre 0.2 U/kg secretin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14742-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin pre 0.2 u/kg SCT SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Before; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; pre 0.2 u/kg SCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14743-9 Glucose SCnc BldC Pt Qn Glucometer &nbsp; ACTIVE Glucose [Moles/volume] in Capillary blood by Glucometer &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14743-9 &nbsp; Glucometer &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose BldC Glucomtr-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Glu; Gluc; Glucomtr; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14744-7 Glucose SCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Cerebral spinal fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14744-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose CSF-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glu; Gluc; Glucoseur; Level; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14745-4 Glucose SCnc Body fld Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Body fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14745-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose Fld-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14746-2 Glucose SCnc Dial fld prt Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Peritoneal dialysis fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14746-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose DiafP-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Glu; Gluc; Glucoseur; Level; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14747-0 Glucose SCnc Plr fld Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Pleural fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14747-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose Plr-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Glu; Gluc; Glucoseur; Level; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thoracentesis fluid 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14748-8 Glucose SCnc Periton fld Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Peritoneal fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14748-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose Prt-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Ascites; Ascitic fluid; Ascitis; Chemistry; Glu; Gluc; Glucoseur; Level; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14749-6 Glucose SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14749-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Glucose SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
1475-3 Follitropin^45M post 100 ug luteinizing releasing hormone IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --45 minutes post 100 ug luteinizing releasing hormone IV &nbsp; NAM DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1475-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FSH 45M p 100 ug LRH IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 45M p 100 ug LRH IV; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
108,248 results found